OMER EBITDA | OMEROS CORP

OMEROS CORP (OMER) EBITDA

2026-06-30: Basis Reported; EBITDA $267.00K*; Operating income $74.00K; Depreciation and amortization $193.00K*.
2026-03-31: Basis Reported; EBITDA -$17.18M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$28.85M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$26.15M*; Operating income -$26.39M; Depreciation and amortization $240.00K*.

Complete source-backed ebitda history.

Available history: 2021-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$267.00K*	$74.00K	$193.00K*	$28.53M	0.94%*	$45.00K*	$4.15M*	$798.00K	$13.80M	$13.86M	$29.00K
2026-03-31	Reported	-$17.18M	(m)	(m)	(m)	-173.68%	$0.00	-$14.51M	$587.00K	$13.36M	$13.37M	$57.00K
2025-12-31	Reported	-$28.85M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$26.15M*	-$26.39M	$240.00K*	(m)	(m)	$11.00K*	-$18.47M*	(m)	$15.99M	$10.40M	(m)
2025-06-30	Reported	-$32.15M*	-$32.35M	$200.00K*	$0.00	(m)	$13.00K*	-$21.94M*	$0.00	$22.01M	$10.35M	$0.00
2025-03-31	Reported	-$34.68M	(m)	(m)	(m)	(m)	$41.00K	-$35.84M	$0.00	$23.85M	$11.12M	$0.00
2024-12-31	Reported	-$33.05M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$35.17M*	-$35.41M	$237.00K*	(m)	(m)	$1.00K*	-$32.06M*	(m)	$24.08M	$11.32M	(m)
2024-06-30	Reported	-$58.95M*	-$59.16M	$208.00K*	(m)	(m)	$80.00K*	-$45.98M*	(m)	$45.35M	$13.81M	(m)
2024-03-31	Reported	-$38.83M	(m)	(m)	(m)	(m)	$58.00K	-$41.78M	(m)	$26.77M	$12.26M	(m)
2023-12-31	Reported	-$39.56M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$47.96M*	-$48.15M	$197.00K*	(m)	(m)	$33.00K*	-$32.65M*	(m)	$31.73M	$16.42M	(m)
2023-06-30	Reported	-$40.57M*	-$40.90M	$332.00K*	(m)	(m)	$275.00K*	-$32.34M*	(m)	$29.64M	$11.26M	(m)
2023-03-31	Reported	-$35.53M	(m)	(m)	(m)	(m)	$0.00	$174.54M	(m)	$24.61M	$11.10M	(m)
2022-12-31	Reported	-$39.98M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	(m)	-$50.77M	(m)	(m)	(m)	-$3.00K*	-$26.44M*	(m)	$38.57M	$12.20M	(m)
2022-06-30	Reported	(m)	-$37.44M	(m)	(m)	(m)	(m)	-$19.47M*	(m)	$23.52M	(m)	(m)
2022-03-31	Reported	(m)	-$35.05M	(m)	(m)	(m)	(m)	-$15.19M	(m)	$24.09M	(m)	(m)
2021-09-30	Reported	(m)	-$39.83M	(m)	$30.00M	(m)	$103.00K*	-$23.66M*	$333.00K	$25.82M	(m)	(m)
2021-06-30	Reported	(m)	-$45.61M	(m)	$28.82M	(m)	$88.00K*	-$27.59M*	$342.00K	$30.13M	(m)	(m)
2021-03-31	Reported	(m)	-$45.29M	(m)	$21.06M	(m)	$12.00K	-$40.25M	$263.00K	$32.50M	(m)	(m)
2020-12-31	Reported	(m)	-$33.82M	(m)	$10.63M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	(m)	-$25.43M	(m)	$26.11M	(m)	$73.00K*	-$34.94M*	$401.00K	$31.32M	(m)	-$7.85M
2020-06-30	Reported	(m)	-$27.68M	(m)	$13.53M	(m)	$144.00K*	-$37.60M*	$147.00K	$24.13M	(m)	(m)
2020-03-31	Reported	(m)	-$23.68M	(m)	$23.54M	(m)	$66.00K	-$9.14M	$267.00K	$28.91M	(m)	(m)
2019-12-31	Reported	(m)	-$23.70M	(m)	$33.42M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	-$11.10M	(m)	$29.86M	(m)	$39.00K*	-$7.52M*	$278.00K	$23.75M	(m)	(m)
2019-06-30	Reported	(m)	-$9.34M	(m)	$26.75M	(m)	$97.00K*	-$16.59M*	$55.00K	$19.11M	(m)	(m)
2019-03-31	Reported	(m)	-$19.24M	(m)	$21.78M	(m)	$182.00K	-$12.95M	$131.00K	$26.25M	(m)	(m)
2018-12-31	Reported	(m)	-$18.47M	(m)	$22.02M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	(m)	-$35.44M	(m)	$4.61M	(m)	$88.00K*	-$36.87M*	$36.00K	$26.86M	(m)	(m)
2018-06-30	Reported	(m)	-$30.62M	(m)	$1.66M	(m)	$203.00K*	-$30.91M*	$116.00K	$19.41M	(m)	(m)
2018-03-31	Reported	(m)	-$27.69M	(m)	$1.59M	(m)	$183.00K	-$11.30M	$203.00K	$18.14M	(m)	(m)
2017-12-31	Reported	(m)	-$14.12M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	(m)	-$5.11M	(m)	(m)	(m)	$34.00K*	-$11.19M*	$184.00K	$14.84M	(m)	(m)
2017-06-30	Reported	(m)	-$11.94M	(m)	(m)	(m)	$244.00K*	-$8.16M*	(m)	$13.14M	(m)	(m)
2017-03-31	Reported	(m)	-$12.72M	(m)	(m)	(m)	$72.00K	-$12.70M	(m)	$12.24M	(m)	(m)
2016-12-31	Reported	(m)	-$11.86M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$12.04M	(m)	(m)	(m)	$44.00K*	-$11.22M*	(m)	$12.49M	(m)	(m)
2016-06-30	Reported	(m)	-$10.93M	(m)	(m)	(m)	$34.00K*	-$12.79M*	(m)	$10.23M	(m)	(m)
2016-03-31	Reported	(m)	-$19.45M	(m)	(m)	(m)	$0.00	-$16.63M	(m)	$15.43M	(m)	(m)
2015-12-31	Reported	(m)	-$18.04M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	(m)	-$19.30M	(m)	(m)	(m)	$73.00K*	-$14.59M*	(m)	$13.26M	(m)	(m)
2015-06-30	Reported	(m)	-$15.97M	(m)	(m)	(m)	$114.00K*	-$16.55M*	(m)	$10.90M	(m)	(m)
2015-03-31	Reported	(m)	-$17.93M	(m)	(m)	(m)	$0.00	-$17.48M	(m)	$9.32M	(m)	(m)
2014-12-31	Reported	(m)	-$19.98M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	(m)	-$17.13M	(m)	(m)	(m)	$10.00K*	-$15.94M*	(m)	$11.77M	(m)	(m)
2014-06-30	Reported	(m)	-$17.22M	(m)	(m)	(m)	-$4.00K*	-$15.27M*	(m)	$12.41M	(m)	(m)
2014-03-31	Reported	(m)	-$15.68M	(m)	(m)	(m)	$6.00K	-$11.14M	(m)	$12.02M	(m)	(m)
2013-12-31	Reported	(m)	-$13.90M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	(m)	-$13.43M	(m)	(m)	(m)	$48.00K*	-$11.04M*	(m)	$9.42M	(m)	(m)
2013-06-30	Reported	(m)	-$13.16M	(m)	(m)	(m)	$1.00K*	-$9.39M*	(m)	$9.56M	(m)	(m)
2013-03-31	Reported	(m)	-$10.02M	(m)	(m)	(m)	$88.00K	-$8.97M	(m)	$7.13M	(m)	(m)
2012-12-31	Reported	(m)	-$7.53M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	(m)	-$13.04M	(m)	(m)	(m)	$90.00K*	-$7.40M*	(m)	$7.76M	(m)	(m)
2012-06-30	Reported	(m)	-$8.24M	(m)	(m)	(m)	(m)	(m)	(m)	$7.56M	(m)	(m)
2012-06-30	Reported	(m)	-$8.24M	(m)	(m)	(m)	$73.00K*	-$8.86M*	(m)	$7.56M	(m)	(m)
2012-03-31	Reported	(m)	-$8.07M	(m)	(m)	(m)	$72.00K	-$5.50M	(m)	$7.25M	(m)	(m)
2011-12-31	Reported	(m)	-$9.85M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	(m)	-$6.16M	(m)	(m)	(m)	$7.00K*	-$4.11M*	(m)	$5.32M	(m)	(m)
2011-06-30	Reported	(m)	-$4.95M	(m)	(m)	(m)	$511.00K*	-$6.33M*	(m)	$4.08M	(m)	(m)
2011-03-31	Reported	(m)	-$6.45M	(m)	(m)	(m)	$682.00K	-$7.88M	(m)	$5.42M	(m)	(m)
2010-09-30	Reported	(m)	-$7.49M	(m)	(m)	(m)	$154.00K*	-$5.90M*	(m)	(m)	(m)	(m)
2010-06-30	Reported	(m)	-$7.63M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$121.83M	(m)	(m)	(m)	(m)	$65.00K	-$116.09M	(m)	$81.30M	$41.50M	$2.01M
2024-12-31	Reported	-$166M	(m)	(m)	(m)	(m)	$165.00K	-$148.80M	(m)	$119.52M	$47.43M	$2.31M
2023-12-31	Reported	-$163.61M	(m)	(m)	(m)	(m)	$426.00K	$74.73M	(m)	$114.87M	$49.66M	$0.00
2022-12-31	Reported	-$162.44M	(m)	(m)	(m)	(m)	$113.00K	-$86.48M	(m)	$112.72M	$50.67M	$0.00
2021-12-31	Reported	-$172.23M	(m)	(m)	(m)	(m)	$277.00K	-$109.72M	(m)	$118.78M	$54.84M	$0.00
2021-09-30	Rolling	(m)	-$164.54M*	(m)	$90.52M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	-$150.14M*	(m)	$86.63M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	-$132.21M*	(m)	$71.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	-$156.92M	(m)	$73.81M	(m)	$283.00K	-$100.09M	$902.00K	$107.61M	(m)	-$23.26M
2020-12-31	Rolling	(m)	-$110.60M*	(m)	$73.81M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$100.49M*	(m)	$96.60M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$86.16M*	(m)	$100.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$67.82M*	(m)	$113.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	-$146.04M	(m)	$111.81M	(m)	$334.00K	-$60.07M	$865.00K	$106.32M	(m)	-$19.77M
2019-12-31	Rolling	(m)	-$63.38M*	(m)	$111.81M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$58.15M*	(m)	$100.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$82.49M*	(m)	$75.16M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$103.77M*	(m)	$50.06M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	(m)	-$112.22M	(m)	$29.87M	(m)	$567.00K	-$103.74M	$512.00K	$89.86M	(m)	-$12.93M
2018-12-31	Rolling	(m)	-$112.22M*	(m)	$29.87M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$107.87M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$77.54M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$58.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	(m)	-$43.90M	(m)	$64.83M	(m)	$350.00K	-$36.23M	$1.08M	$55.60M	(m)	$0.00
2017-12-31	Rolling	(m)	-$43.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$41.63M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$48.56M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$47.55M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	(m)	-$54.28M	(m)	(m)	(m)	$126.00K	-$51.50M	$1.41M	$50.70M	(m)	$0.00
2016-12-31	Rolling	(m)	-$54.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$60.46M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$67.72M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$72.76M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	(m)	-$71.24M	(m)	(m)	(m)	$240.00K	-$65.21M	(m)	$48.38M	(m)	(m)
2015-12-31	Rolling	(m)	-$71.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$73.17M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$71.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$72.25M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	(m)	-$70.01M	(m)	(m)	(m)	$28.00K	-$58.04M	(m)	$47.95M	(m)	(m)
2014-12-31	Rolling	(m)	-$70.01M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$63.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$60.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$56.18M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	(m)	-$50.52M	(m)	(m)	(m)	$204.00K	-$29.70M	(m)	$36.30M	(m)	(m)
2013-12-31	Rolling	(m)	-$50.52M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	-$44.15M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Rolling	(m)	-$43.75M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	(m)	-$36.88M	(m)	(m)	(m)	$642.00K	-$34.55M	(m)	$31.92M	(m)	(m)
2012-03-31	Rolling	(m)	-$29.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	(m)	-$27.41M	(m)	(m)	(m)	$1.24M	-$25.67M	(m)	$23.72M	(m)	(m)
2011-12-31	Rolling	(m)	-$27.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	(m)	-$30.11M	(m)	(m)	(m)	$807.00K	-$14.50M	(m)	$23.46M	(m)	(m)
2009-12-31	Reported	(m)	-$20.76M	(m)	(m)	(m)	$279.00K	-$19.03M	(m)	$16.93M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)	United States	$1.456B	-5.62
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Innoviva, Inc. (INVA)	United States	$1.493B	4.62
Oric Pharmaceuticals, Inc. (ORIC)	United States	$1.367B	-8.00
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
Kardigan, Inc. (KARD)	United States	$1.346B
Tyra Biosciences, Inc. (TYRA)	United States	$1.337B	-12.83
Bicara Therapeutics Inc. (BCAX)	United States	$1.309B	-10.55
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82